Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Wall Street Opens Higher as Jobless Claims Bolster Fed Hopes; Dow up 420 Pts

Published 09/23/2021, 09:40 AM
Updated 09/23/2021, 09:52 AM
© Reuters.

© Reuters.

By Geoffrey Smith 

Investing.com -- U.S. stock markets opened higher on Thursday, extending Wednesday's gains on growing hopes that China can avoid a messy deleveraging of its real estate sector, and that the Federal Reserve may yet put off tightening monetary policy beyond the end of the year.

By 9:40 AM ET (1340 GMT), the Dow Jones Industrial Average was up 416 points, or 1.2%, at 34,675 points. The S&P 500 was up 1.0% and the Nasdaq Composite was up 0.7%.

Fed Chair Jerome Powell had hinted at Wednesday's press conference that the process of 'tapering' bond purchases would begin later this year, and be completed by the middle of 2022. However, this week's jobless claims data, which followed a much weaker-than-expected labor market report for August, have encouraged those who believe that the Fed will keep its foot to the floor for a little longer.

Earlier, the U.S. notched 351,000 initial jobless claims last week, more than expected and a second straight weekly increase, suggesting that the Delta-variant Covid-19 surge seen during the summer is finally feeding through into lay-offs. Some analysts noted however that seasonal factors and disruptions from two hurricanes may also have contributed to the uptick. 

Continuing claims also came in above expectations, while IHS Markit's Purchasing Manager Index for the U.S. economy fell by more than expected. While Markit's PMI isn't as closely followed in the U.S. as the Institute of Supply Management's it does point to a clear slowdown in September.

Novavax (NASDAQ:NVAX) stock was the standout performer in early trading, rising 9.5% after the biotech company said it had applied to the World Health Organization, along with its partner the Serum Institute of India, for an emergency use approval of its Covid-19 vaccine. According to the results of a phase-3 trial of the drug published earlier Thursday in the U.K., the vaccine was 89.7% effective in preventing serious illness and no participants who took the drug were admitted to hospital with any side-effects. 

Salesforce (NYSE:CRM) stock also performed strongly after the business software company raised its revenue forecast for the fiscal 2022 year, ending in January, and guided for revenue growth of over 20% in fiscal 2023. The stock rose 5.0%. Accenture (NYSE:ACN) stock also rose 1.3% after slightly stronger-than-expected earnings and guidance.

FedEx (NYSE:FDX) stock continued to underperform after its disappointing quarterly update on Tuesday, but the logistics firm appeared to find a short-term bottom, eking out a 0.2% gain. 

Elsewhere, Roku (NASDAQ:ROKU) stock rose 2.8% after an upgrade to buy from Guggenheim, citing the advances it is making in the international market. 

Aterian (NASDAQ:ATER) stock was a rare decliner, falling 25% after announcing it would issue $66 million in new stock to pay down most of a loan to its biggest creditor, High Trail.

Latest comments

meanwhile, crackhouses built in the '70s are going for $300k in my city.  no showings are allowed until police remove the crime scene tape but you'll love the upgraded kitchen sink backsplash
You can buy a run down 1950s shack in california. For 800 k.
There's always someone in the chain you can blame. Even if its 1 out of five.Find one at a city, county, state, or federal level. If you cant, then branch out to the legislative or judicial branches of the aforementioned to find someone to blame.You could notice that the duopoly of politicking is the disease.
Initial jobless claim went up because of the person who left the company because they didn't want to be vaccinated. It's temporary.
it's ok, after temporary they will sing quick rebound song
😂😂
unexpected indeed closing weekly HH wow
Fraud goes pedal to the metal in the biggest investment JOKE in history.
These mkt commentaries are unreadable. Why don't u scribacchine write each day one episode of Pinocchio or some other good stuff and stop insulting even the most basic level of human intelligence not to mention decency. Really, I can't find a bad enough word to address these authors
haha ********list renewed time for a review. win for me, loose loose for you. lol
Hope for free money to wallstreet is again renewed wirh bad news
KEKW
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.